BindingDB Entry 50018895: Dual Kinase-Bromodomain Inhibitors in Anticancer Drug Discovery: A Structural and Pharmacological Perspective.

Small molecule binding data for protein Bromodomain testis-specific protein, Bromodomain-containing protein 4, Cyclin-dependent kinase 1, Cyclin-dependent kinase 2, Cyclin-dependent kinase 4, Cyclin-dependent kinase 5, Cyclin-dependent kinase 9, DNA-dependent protein kinase catalytic subunit, Dual specificity protein kinase TTK, Epidermal growth factor receptor, Focal adhesion kinase 1, Glycogen synthase kinase-3 alpha, Glycogen synthase kinase-3 beta, Mitogen-activated protein kinase 11, Mitogen-activated protein kinase 14, Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform, Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform, Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform, Platelet-derived growth factor receptor alpha/beta, Protein-tyrosine kinase 2-beta, Proto-oncogene tyrosine-protein kinase receptor Ret, Receptor tyrosine-protein kinase erbB-2, Receptor tyrosine-protein kinase erbB-4, Receptor-type tyrosine-protein kinase FLT3, Ribosomal protein S6 kinase alpha-1, Ribosomal protein S6 kinase alpha-2, Ribosomal protein S6 kinase alpha-3, Ribosomal protein S6 kinase alpha-6, Serine/threonine-protein kinase PLK1, Serine/threonine-protein kinase PLK2, Serine/threonine-protein kinase PLK3, Serine/threonine-protein kinase mTOR, Tyrosine-protein kinase JAK2, Tyrosine-protein kinase SYK, and Vascular endothelial growth factor receptor 2, Uniprot O00329, O60674, O60885, P00533, P04626, P05622, P06493, P07949, P11802, P24941, P26618, P33981, P35968, P36888, P42336, P42345, P43405, P48736, P49840, P49841, P50750, P51812, P53350, P78527, Q00535, Q05397, Q14289, Q15303, Q15349, Q15418, Q15759, Q16539, Q58F21, Q9H4B4, Q9NYY3, and Q9UK32